<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 05 Jan 2022 08:18:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>MediLynx Announces Patent Awarded for Mobile ECG Streaming and Monitoring</title>
   <link>http://www.streetinsider.com/Press+Releases/MediLynx+Announces+Patent+Awarded+for+Mobile+ECG+Streaming+and+Monitoring/19422558.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MediLynx+Announces+Patent+Awarded+for+Mobile+ECG+Streaming+and+Monitoring/19422558.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/MediLynx+Announces+Patent+Awarded+for+Mobile+ECG+Streaming+and+Monitoring/19422558.html</guid>
   <pubDate>Wed, 05 Jan 2022 08:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>MediLynx Announces Patent Awarded for Mobile ECG Streaming and Monitoring</title>
   <link>http://www.streetinsider.com/PRNewswire/MediLynx+Announces+Patent+Awarded+for+Mobile+ECG+Streaming+and+Monitoring/19422558.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/MediLynx+Announces+Patent+Awarded+for+Mobile+ECG+Streaming+and+Monitoring/19422558.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/MediLynx+Announces+Patent+Awarded+for+Mobile+ECG+Streaming+and+Monitoring/19422558.html</guid>
   <pubDate>Wed, 05 Jan 2022 08:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</guid>
   <pubDate>Tue, 18 May 2021 01:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</guid>
   <pubDate>Tue, 18 May 2021 01:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</guid>
   <pubDate>Tue, 18 May 2021 01:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</guid>
   <pubDate>Tue, 18 May 2021 01:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</guid>
   <pubDate>Tue, 18 May 2021 01:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Announce+Positive+Interim+Phase+2+Results+for+Adjuvanted+COVID-19+Vaccine+Candidate/18435373.html</guid>
   <pubDate>Tue, 18 May 2021 01:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Health Canada Initiates the Review of the Rolling Submission for the First Canadian-Based COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Press+Releases/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html</guid>
   <pubDate>Fri, 23 Apr 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Health Canada Initiates the Review of the Rolling Submission for the First Canadian-Based COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Press+Releases/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html</guid>
   <pubDate>Fri, 23 Apr 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Health Canada Initiates the Review of the Rolling Submission for the First Canadian-Based COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Business+Wire/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html</guid>
   <pubDate>Fri, 23 Apr 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Health Canada Initiates the Review of the Rolling Submission for the First Canadian-Based COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Business+Wire/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Health+Canada+Initiates+the+Review+of+the+Rolling+Submission+for+the+First+Canadian-Based+COVID-19+Vaccine+Candidate/18300743.html</guid>
   <pubDate>Fri, 23 Apr 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</guid>
   <pubDate>Tue, 16 Mar 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</guid>
   <pubDate>Tue, 16 Mar 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</guid>
   <pubDate>Tue, 16 Mar 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</guid>
   <pubDate>Tue, 16 Mar 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</guid>
   <pubDate>Tue, 16 Mar 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Medicago and GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate</title>
   <link>http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Medicago+and+GSK+Start+Phase+3+Trial+of+Adjuvanted+COVID-19+Vaccine+Candidate/18131667.html</guid>
   <pubDate>Tue, 16 Mar 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.00809188</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Takashi Nagao Appointed President and Chief Executive Officer of Medicago</title>
   <link>http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</guid>
   <pubDate>Fri, 04 Dec 2020 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23422451</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26182308</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26702646</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Takashi Nagao Appointed President and Chief Executive Officer of Medicago</title>
   <link>http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</guid>
   <pubDate>Fri, 04 Dec 2020 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23422451</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26182308</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26702646</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Takashi Nagao Appointed President and Chief Executive Officer of Medicago</title>
   <link>http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</guid>
   <pubDate>Fri, 04 Dec 2020 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23422451</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26182308</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26702646</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Takashi Nagao Appointed President and Chief Executive Officer of Medicago</title>
   <link>http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</guid>
   <pubDate>Fri, 04 Dec 2020 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23422451</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26182308</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26702646</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Takashi Nagao Appointed President and Chief Executive Officer of Medicago</title>
   <link>http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</guid>
   <pubDate>Fri, 04 Dec 2020 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23422451</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26182308</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26702646</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Takashi Nagao Appointed President and Chief Executive Officer of Medicago</title>
   <link>http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</guid>
   <pubDate>Fri, 04 Dec 2020 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23422451</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26182308</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26702646</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
  <item>
   <title>Takashi Nagao Appointed President and Chief Executive Officer of Medicago</title>
   <link>http://www.streetinsider.com/Business+Wire/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Takashi+Nagao+Appointed+President+and+Chief+Executive+Officer+of+Medicago/17683858.html</guid>
   <pubDate>Fri, 04 Dec 2020 11:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.23422451</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26182308</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.26702646</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38925042</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MDG</category>
   	  </item>
 </channel>
</rss>
